These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7594735)
1. Effect of azoles on the glucuronidation of zidovudine by human liver UDP-glucuronosyltransferase. Asgari M; Back DJ J Infect Dis; 1995 Dec; 172(6):1634-6. PubMed ID: 7594735 [No Abstract] [Full Text] [Related]
2. Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes. Sampol E; Lacarelle B; Rajaonarison JF; Catalin J; Durand A Br J Clin Pharmacol; 1995 Jul; 40(1):83-6. PubMed ID: 8527274 [TBL] [Abstract][Full Text] [Related]
3. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of azole antifungal agents on the glucuronidation of lorazepam using rabbit liver microsomes in vitro. Sawamura R; Sato H; Kawakami J; Iga T Biol Pharm Bull; 2000 May; 23(5):669-71. PubMed ID: 10823688 [TBL] [Abstract][Full Text] [Related]
5. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans. Samonis G; Maraki S; Hajiioannou I; Chatzinikolaou I; Rolston KV; Bodey GP; Kontoyiannis DP J Chemother; 2001 Feb; 13(1):66-9. PubMed ID: 11233803 [TBL] [Abstract][Full Text] [Related]
6. Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP). Gupta A; Unadkat JD; Mao Q J Pharm Sci; 2007 Dec; 96(12):3226-35. PubMed ID: 17518356 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Back DJ; Tjia JF Br J Clin Pharmacol; 1991 Nov; 32(5):624-6. PubMed ID: 1659439 [TBL] [Abstract][Full Text] [Related]
8. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620 [TBL] [Abstract][Full Text] [Related]
9. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs. Venkateswarlu K; Denning DW; Kelly SL J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581 [TBL] [Abstract][Full Text] [Related]
10. Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Trapnell CB; Klecker RW; Jamis-Dow C; Collins JM Antimicrob Agents Chemother; 1998 Jul; 42(7):1592-6. PubMed ID: 9660989 [TBL] [Abstract][Full Text] [Related]
11. Zidovudine glucuronidation in human liver: interindividual variability. Pacifici GM; Evangelisti L; Giuliani L; Metelli RM; Giordani R Int J Clin Pharmacol Ther; 1996 Aug; 34(8):329-34. PubMed ID: 8864794 [TBL] [Abstract][Full Text] [Related]
12. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod]. Guinet R; Marlier H Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937 [TBL] [Abstract][Full Text] [Related]
13. [Antifungal agent resistance of yeasts of clinical significance]. Odds FC Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307 [No Abstract] [Full Text] [Related]
14. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole. Nguyen MH; Yu CY J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846 [TBL] [Abstract][Full Text] [Related]
15. In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans. Raungrut P; Uchaipichat V; Elliot DJ; Janchawee B; Somogyi AA; Miners JO J Pharmacol Exp Ther; 2010 Aug; 334(2):609-18. PubMed ID: 20484152 [TBL] [Abstract][Full Text] [Related]
16. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole]. Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960 [TBL] [Abstract][Full Text] [Related]
17. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine. Sun H; Zhang T; Wu Z; Wu B J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417 [TBL] [Abstract][Full Text] [Related]
18. Antifungal activities of azole agents against the Malassezia species. Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320 [TBL] [Abstract][Full Text] [Related]
19. Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stress. Wang K; Zhang Z; Chen X; Sun X; Jin C; Liu H; Li S Antimicrob Agents Chemother; 2015 Sep; 59(9):5396-404. PubMed ID: 26100701 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles. Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]